Institutional investors purchased a net $412.0 thousand shares of SRPT during the quarter ended March 2015, and now own 60.81% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POINTSTATE CAPITAL LP Bought 500.0 Thousand shares of Sarepta Therapeutics Inc